Acute leukemia in a patient with sickle-cell anemia treated with hydroxyurea [10]

Annals of Internal Medicine

Volumn 133, Issue 11, 2000, Pages 925-926

  Wilson, S ^a  

^a El Rio Health Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A2; HEMOGLOBIN S; HYDROXYUREA;

ACUTE LEUKEMIA; ADULT; BONE MARROW BIOPSY; CASE REPORT; DISEASE ASSOCIATION; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LETTER; PRIORITY JOURNAL; SICKLE CELL ANEMIA; THROMBOCYTE COUNT;

EID: 0034610262     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-133-11-200012050-00029     Document Type: Letter

References (4)

1. Treatment of polycythemia vera: Use of 32P alone or in combination with maintenance therapy using hydroxyurea in 461 patients greater than 65 years of age. The French Polycythemia Study Group
2. Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: High proportion of cases with 17p deletion
3. Leukemogenesis of hydroxyurea in the treatment of sickle cell anemia
4. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia